miércoles, 21 de enero de 2026

Medicaid Tries New Approach With Sickle Cell: Companies Get Paid Only if Costly Gene Therapies Work By Phil Galewitz January 21, 2026

https://kffhealthnews.org/news/article/sickle-cell-disease-gene-therapy-medicaid-vertex-bluebird-bio/

No hay comentarios: